Literature DB >> 25780322

Surgical, interventional, and device innovations in the management of hypertension.

Sibu P Saha1, Khaled M Ziada2, Thomas F Whayne2.   

Abstract

The prevalence of hypertension around the world has increased significantly with projections for an increasing major global burden of hypertension. Medication-resistant hypertension can be perplexing and frustrating. The existence of these difficult patients results in the need for additional approaches to treatment including surgery, percutaneous interventions, and device management. The sophistication of these techniques has progressed markedly and initial procedures such as classical sympathectomy and renal artery bypass are almost never performed. Newer techniques of angioplasty with stenting, renal artery denervation, and baroreflex activation therapy via electrical stimulation of the carotid baroreceptors are now in use with increasing evidence for significant benefit.

Entities:  

Keywords:  hypertension; renal artery denervation; renal artery stenting; resistant hypertension; sympathectomy

Year:  2015        PMID: 25780322      PMCID: PMC4347828          DOI: 10.1055/s-0034-1374808

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  56 in total

Review 1.  Balloon angioplasty is preferred to surgery for aortic coarctation.

Authors:  Derek Wong; Lee N Benson; Glen S Van Arsdell; Tara Karamlou; Brian W McCrindle
Journal:  Cardiol Young       Date:  2008-01-21       Impact factor: 1.093

Review 2.  Does surgical correction of coarctation of the aorta in adults reduce established hypertension?

Authors:  Hunaid A Vohra; Louise Adamson; Marcus P Haw
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-09-19

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

Review 4.  Resistant hypertension, obstructive sleep apnoea and aldosterone.

Authors:  T Dudenbostel; D A Calhoun
Journal:  J Hum Hypertens       Date:  2011-06-09       Impact factor: 3.012

5.  Baroreceptor sensitivity, cardiovascular responses and ECG left ventricular hypertrophy in men: the SABPA study.

Authors:  Lisa van Lill; Leon Malan; Johannes van Rooyen; Faans Steyn; Manja Reimann; Tjalf Ziemssen
Journal:  Blood Press       Date:  2011-05-06       Impact factor: 2.835

6.  Comparison of surgical repair with balloon angioplasty for native coarctation in patients from 3 months to 16 years of age.

Authors:  Ronald J Walhout; Jaco C Lekkerkerker; Gordon H Oron; Ger B W E Bennink; Erik J Meijboom
Journal:  Eur J Cardiothorac Surg       Date:  2004-05       Impact factor: 4.191

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Coarctation of the aorta life and health 20-44 years after surgical repair.

Authors:  A B Stewart; R Ahmed; C M Travill; C G Newman
Journal:  Br Heart J       Date:  1993-01

9.  Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension.

Authors:  Byung-Hee Oh; Jerry Mitchell; James R Herron; Jenny Chung; Mahmudul Khan; Deborah L Keefe
Journal:  J Am Coll Cardiol       Date:  2007-03-20       Impact factor: 24.094

Review 10.  First-line drugs for hypertension.

Authors:  James M Wright; Vijaya M Musini
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.